Poland Plans Total Prohibition of Single-Use Vapes to Protect Youth

Nov.25.2025
Poland Plans Total Prohibition of Single-Use Vapes to Protect Youth
Poland’s Ministry of Health has proposed legislation to ban all disposable e-cigarettes — both with and without nicotine — under a new amendment to tobacco product laws. The government aims to protect youth from nicotine addiction while reducing public health and environmental harm. Medical professionals largely support the move but call for balanced harm-reduction strategies.

Key Points

 

  • The draft law UD213 seeks a total ban on disposable e-cigarettes, including nicotine-free devices.
  • The Ministry of Health highlights the addictive appeal and environmental hazards of single-use vapes.
  • Nicotine pouches, gums, sprays, and drinks would also fall under stricter regulation.
  • Doctors support the ban; pharmacists urge retention of regulated nicotine pouches for adults.
  • Public debate calls for a national harm-reduction strategy rather than blanket prohibition.

 


 

2Firsts, November 25, 2025 - According to Polish media Strefa Biznesu, Poland’s government is moving forward with a bill (UD213) that would introduce a total ban on disposable e-cigarettes, regardless of nicotine content. The Ministry of Health says the measure is designed to protect youth from nicotine addiction and to limit both health and environmental damage caused by such products.

 

The ministry noted that disposable vapes:

 

  • Have high marketing appeal, particularly to young users;
  • Are ready-to-use and highly addictive;
  • Contain toxic and immunosuppressive substances;
  • Are difficult to recycle due to their plastic bodies and lithium-ion batteries.

 

The bill would also bring nicotine pouches and other emerging nicotine products — such as gums, sprays, and beverages — under a pharmaceutical-style regime, restricting their sale and distribution. Poland’s Office for Chemical Substances would be empowered to order composition testing of e-liquid formulations.

 

Medical experts broadly support the ban as a key step in public health protection but urge policymakers not to overreach.

Pulmonologist Dr. Katarzyna Kołcz wrote in a letter to Health Minister Maciej Berek that single-use vapes pose a serious threat to youth:

 

“These products have an exceptionally high potential to initiate nicotine addiction among young people — especially because of their attractive design, colorful packaging, and aggressive marketing.”

 

Pharmacists, however, signed a letter from Dr. Dawid Panek calling for adult access to nicotine pouches to remain legal:

 

“Although these products are not medical devices, their pharmacological and toxicological profiles resemble nicotine replacement therapies (NRT). They do not involve the respiratory system and thus present fewer health risks.”

 

Both medical and pharmaceutical groups argue that Poland’s anti-nicotine policy should combine restrictions with harm-reduction strategies. Their proposals include:

 

Maintaining adult access to smokeless nicotine alternatives;

Implementing strict composition and labeling controls;

Allowing certain flavors (e.g., mint) to support cessation programs;

Developing a national anti-nicotine strategy modeled on Sweden and New Zealand, where regulated smokeless products have successfully reduced smoking rates.

 

 


 

 

Open Letter to the President

 

 

The Jump 93 Association sent an open letter to President Karol Nawrocki (卡罗尔·纳夫罗茨基), calling for an open national debate on nicotine policy. The organization criticized the Health Ministry for ignoring months of requests for a transparent, science-based discussion.

 

The letter warns that equating the risks of traditional cigarettes with alternative nicotine forms — such as pouches and e-cigarettes — contradicts scientific evidence and international experience.

 

“Conventional cigarettes cause the greatest harm. Transitioning to less harmful nicotine products forms the basis of anti-nicotine policies in countries like Sweden, New Zealand, and the UK,” said Jacek Charmast, president of Jump 93.

 

The organization stressed that silencing harm-reduction advocates stigmatizes scientific perspectives and undermines efforts to protect both youth and smokers seeking to quit.

 

Image source: Strefa Biznesu

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
SMOORE-owned vaping brand VAPORESSO introduced the VAST refillable open-system vape in October 2026, featuring Tri-Core Mesh technology that integrates three resistance configurations—0.8Ω, 0.6Ω and 0.4Ω—within a single pod. The device supports different operating modes and e-liquid types. The standard version features a 10mL pod, while a TPD-labelled configuration combines a 2mL pod with an 8mL refill container. The device has a 1,600mAh battery and a maximum output of 30W. VAPORESSO claims up to six pod refills and a tested coil lifespan of up to 150,000 puffs. The UK's MHRA published a related device notification on October 12. The official MSRP is $25.90, compared with a $35.90 listing on VAPORESSO's direct store.
product
Oct.30
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
Philip Morris International's IQOS has extended its partnership with electronic-music event brand ZAMNA to Spain, setting up a House of IQOS at ZAMNA Madrid. Vogue España and Time Out Madrid subsequently published branded content clearly labeled as collaborations with IQOS. PMI has also expanded its company-owned IQOS boutique network in Spain to seven cities this year. The company says IQOS's adjusted heated-tobacco market share in Europe reached 12.6% in the first quarter of 2026, with Spain among its stronger-performing European markets.
Sep.20
PMI Launches Fourth IQOS Convenience-Store Discount of 2026 for Black Friday in Japan, Cutting ILUMA i ONE to About $19 After Ploom AURA Fell to About $9
PMI Launches Fourth IQOS Convenience-Store Discount of 2026 for Black Friday in Japan, Cutting ILUMA i ONE to About $19 After Ploom AURA Fell to About $9
Philip Morris Japan launched its fourth confirmed nationwide convenience-store discount campaign for IQOS ILUMA i devices in 2026 on October 26, cutting three models by as much as ¥2,000, or about $12.70. The campaign began one day after JT ended a promotion that reduced Ploom AURA to ¥1,480, or about $9.40. JT says Ploom's share of Japan's heated-products category rose from 10.9% in January 2024 to 18.3% in June 2026, a gain of 7.4 percentage points, while PMI says IQOS still held about 68% category share in the third quarter. At the same time, Japan's two-stage heated-tobacco tax adjustment has pushed stick prices higher, leaving device discounts as an increasingly important tool for lowering the upfront cost of customer acquisition.
Market
Oct.28
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives